Annual Revenue:
$2.26B-$90.98M(-3.86%)Summary
- As of April 3, 2025, RPRX annual revenue is $2.26 billion, with the most recent change of -$90.98 million (-3.86%) on December 31, 2024.
- During the last 3 years, RPRX annual revenue has fallen by -$25.89 million (-1.13%).
- RPRX annual revenue is now -3.86% below its all-time high of $2.35 billion, reached on December 31, 2023.
Performance
RPRX Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Revenue:
$593.64M+$28.95M(+5.13%)Summary
- As of April 3, 2025, RPRX quarterly revenue is $593.64 million, with the most recent change of +$28.95 million (+5.13%) on December 31, 2024.
- Over the past year, RPRX quarterly revenue has dropped by -$2.43 million (-0.41%).
- RPRX quarterly revenue is now -13.21% below its all-time high of $683.97 million, reached on March 31, 2023.
Performance
RPRX Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Revenue:
$2.26B-$2.43M(-0.11%)Summary
- As of April 3, 2025, RPRX TTM revenue is $2.26 billion, with the most recent change of -$2.43 million (-0.11%) on December 31, 2024.
- Over the past year, RPRX TTM revenue has dropped by -$90.98 million (-3.86%).
- RPRX TTM revenue is now -4.14% below its all-time high of $2.36 billion, reached on June 30, 2023.
Performance
RPRX TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
RPRX Revenue Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -3.9% | -0.4% | -3.9% |
3 y3 years | -1.1% | -0.4% | -3.9% |
5 y5 years | +24.8% | -0.4% | -3.9% |
RPRX Revenue Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -3.9% | +1.2% | -13.2% | +10.8% | -4.1% | +1.2% |
5 y | 5-year | -3.9% | +24.8% | -13.2% | +18.5% | -4.1% | +20.4% |
alltime | all time | -3.9% | +41.7% | -13.2% | +36.5% | -4.1% | +420.5% |
Royalty Pharma Revenue History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2024 | $2.26B(-3.9%) | $593.64M(+5.1%) | $2.26B(-0.1%) |
Sep 2024 | - | $564.69M(+5.1%) | $2.27B(+1.3%) |
Jun 2024 | - | $537.27M(-5.4%) | $2.24B(-0.0%) |
Mar 2024 | - | $567.98M(-4.7%) | $2.24B(-4.9%) |
Dec 2023 | $2.35B(+5.2%) | $596.07M(+11.1%) | $2.35B(+1.3%) |
Sep 2023 | - | $536.31M(-0.4%) | $2.32B(-1.6%) |
Jun 2023 | - | $538.20M(-21.3%) | $2.36B(+0.1%) |
Mar 2023 | - | $683.97M(+20.9%) | $2.36B(+5.4%) |
Dec 2022 | $2.24B(-2.3%) | $565.75M(-1.3%) | $2.24B(-0.4%) |
Sep 2022 | - | $573.46M(+7.0%) | $2.25B(-0.5%) |
Jun 2022 | - | $535.96M(-4.6%) | $2.26B(-0.8%) |
Mar 2022 | - | $562.05M(-2.4%) | $2.28B(-0.5%) |
Dec 2021 | $2.29B | $575.70M(-1.7%) | $2.29B(+0.2%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2021 | - | $585.77M(+5.6%) | $2.29B(+2.1%) |
Jun 2021 | - | $554.96M(-3.2%) | $2.24B(+2.0%) |
Mar 2021 | - | $573.03M(+0.2%) | $2.19B(+3.4%) |
Dec 2020 | $2.12B(+17.0%) | $572.14M(+6.3%) | $2.12B(+5.7%) |
Sep 2020 | - | $538.40M(+5.4%) | $2.01B(+3.8%) |
Jun 2020 | - | $510.93M(+2.0%) | $1.93B(+2.8%) |
Mar 2020 | - | $500.88M(+9.5%) | $1.88B(+3.6%) |
Dec 2019 | $1.81B(+1.1%) | $457.49M(-1.5%) | $1.81B(+33.7%) |
Sep 2019 | - | $464.28M(+1.5%) | $1.36B(+52.0%) |
Jun 2019 | - | $457.61M(+5.2%) | $892.49M(+105.2%) |
Mar 2019 | - | $434.88M | $434.88M |
Dec 2018 | $1.79B(+12.3%) | - | - |
Dec 2017 | $1.60B | - | - |
FAQ
- What is Royalty Pharma annual revenue?
- What is the all time high annual revenue for Royalty Pharma?
- What is Royalty Pharma annual revenue year-on-year change?
- What is Royalty Pharma quarterly revenue?
- What is the all time high quarterly revenue for Royalty Pharma?
- What is Royalty Pharma quarterly revenue year-on-year change?
- What is Royalty Pharma TTM revenue?
- What is the all time high TTM revenue for Royalty Pharma?
- What is Royalty Pharma TTM revenue year-on-year change?
What is Royalty Pharma annual revenue?
The current annual revenue of RPRX is $2.26B
What is the all time high annual revenue for Royalty Pharma?
Royalty Pharma all-time high annual revenue is $2.35B
What is Royalty Pharma annual revenue year-on-year change?
Over the past year, RPRX annual revenue has changed by -$90.98M (-3.86%)
What is Royalty Pharma quarterly revenue?
The current quarterly revenue of RPRX is $593.64M
What is the all time high quarterly revenue for Royalty Pharma?
Royalty Pharma all-time high quarterly revenue is $683.97M
What is Royalty Pharma quarterly revenue year-on-year change?
Over the past year, RPRX quarterly revenue has changed by -$2.43M (-0.41%)
What is Royalty Pharma TTM revenue?
The current TTM revenue of RPRX is $2.26B
What is the all time high TTM revenue for Royalty Pharma?
Royalty Pharma all-time high TTM revenue is $2.36B
What is Royalty Pharma TTM revenue year-on-year change?
Over the past year, RPRX TTM revenue has changed by -$90.98M (-3.86%)